Вклад участника
- 21:19, 28 марта 2024 (разн. | история) . . (+3613) . . Н Everolimus-plus-bevacizumab-is-an-efficient-firstline-answer-to-individuals-together-with-superior-papillary-variant-kidney-cellular-carcinoma-Final-results-coming-from-a-period-Two-test-v (Everolimus-plus-bevacizumab-is-an-efficient-firstline-answer-to-individuals-together-with-superior-papillary-variant-kidney-cellular-carcinoma-Final-results-coming-from-a-period-Two-test-v) (текущая)